4//SEC Filing
Lykins Charmaine 4
Accession 0000899243-21-046318
CIK 0001771917other
Filed
Nov 29, 7:00 PM ET
Accepted
Nov 30, 5:12 PM ET
Size
5.4 KB
Accession
0000899243-21-046318
Insider Transaction Report
Form 4
Lykins Charmaine
Chief Commercial Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-11-29+75,000→ 75,000 totalExercise: $125.52Exp: 2031-11-28→ Common Stock (75,000 underlying)
Footnotes (1)
- [F1]25% of this option shall vest on November 29, 2022, and the remaining 75% shall vest in twelve equal three-month installments over the following three years, subject to continued service through such dates.
Documents
Issuer
Karuna Therapeutics, Inc.
CIK 0001771917
Entity typeother
Related Parties
1- filerCIK 0001895689
Filing Metadata
- Form type
- 4
- Filed
- Nov 29, 7:00 PM ET
- Accepted
- Nov 30, 5:12 PM ET
- Size
- 5.4 KB